Radiosensitisation of Hepatocellular Carcinoma Cells by Vandetanib

Hepatocellular Carcinoma (HCC) is increasing in incidence worldwide and requires new approaches to therapy. The combination of anti-angiogenic drug therapy and radiotherapy is one promising new approach. The anti-angiogenic drug vandetanib is a tyrosine kinase inhibitor of vascular endothelial growt...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Principais autores: Znati, Sami, Carter, Rebecca, Vasquez, Marcos, Westhorpe, Adam, Shahbakhti, Hassan, Prince, Jessica, Vlckova, Petra, De Vellis, Chiara, Bascal, Zainab, Loizidou, Marilena, Sharma, Ricky A.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7408860/
https://ncbi.nlm.nih.gov/pubmed/32668592
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12071878
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados